Defiance ETFs proudly unveils LLYX, the world's first single-stock
leveraged ETF for Eli Lilly. LLYX offers retail investors 2X daily
long leveraged exposure to the change in the daily share price of
Eli Lilly without the need for a margin account, providing a unique
tool for tactical traders. LLYX does not invest directly in Eli
Lilly and has a higher degree of risk due to tracking a single
stock.
Eli Lilly and Company, established in 1876 and headquartered in
Indianapolis, Indiana, is a global leader in the pharmaceutical
industry, renowned for its innovative approach to medicine. Eli
Lilly is particularly noted for its advancements in diabetes care,
including its development of GLP-1 (Glucagon-Like Peptide-1)
receptor agonists such as Trulicity (dulaglutide) and the novel
dual GLP-1 and GIP agonist Tirzepatide.
"Our new ETF, LLYX, allows investors to gain enhanced exposure
to the share price movement of Eli Lilly stock, a company at the
forefront of the weight loss revolution with GLP-1 receptor
agonists," said Sylvia Jablonski, CEO of Defiance ETFs. "We believe
the advancements in GLP-1 therapies represent a
multi-trillion-dollar opportunity, and we are excited to provide
investors with a groundbreaking trading tool to participate in this
transformative sector."
About Defiance ETFs
Founded in 2018, Defiance stands as a leading ETF issuer
dedicated to income and thematic investing. Defiance also pioneers
leveraged ETFs designed for traders seeking tactical
opportunities.
Our suite of first-mover leveraged & thematic ETFs
empowers investors to express targeted views on disruptive
innovations, including artificial intelligence, machine learning,
and quantum computing, while our actively managed options ETFs are
designed to seek current income.
Important Disclosures
The Funds' investment objectives, risks, charges, and expenses
must be considered carefully before investing. The prospectus
contains this and other important information about the investment
company. Please read carefully before investing. A hard copy of the
prospectuses can be requested by calling 833.333.9383.
The fund attempts to provide daily investment results
that correspond to two times (200%) the share price performance of
an underlying exchange-traded fund (an "Underlying Security"). The
Fund is not intended to be used by, and is not appropriate for,
investors who do not intend to actively monitor and manage their
portfolios. The Fund is very different from most mutual funds and
exchange-traded funds.
The Fund’s investment adviser will not attempt to
position a Fund's portfolio to ensure that the Fund does not gain
or lose more than a maximum percentage of its net asset value on a
given trading day. As a consequence, if an Underlying Security's
share price referenced by a Fund decreases by more than 50% on a
given trading day, the corresponding Fund's investors could lose
all of their money.
The Fund is not suitable for all investors. The Fund is designed
to be utilized only by knowledgeable investors who understand the
potential consequences of seeking daily leveraged (2X) investment
results, understand the risks associated with the use of leverage,
and are willing to monitor their portfolios frequently. The Fund is
not intended to be used by, and is not appropriate for, investors
who do not intend to actively monitor and manage their portfolios.
For periods longer than a single day, the Fund will lose money if
the Underlying Security’s performance is flat, and it is possible
that the Fund will lose money even if the Underlying Security’s
performance increases over a period longer than a single day. An
investor could lose the full principal value of his/her investment
within a single day.
Because of daily rebalancing and the compounding of each day’s
return over time, the return of the Fund for periods longer than a
single day will be the result of each day’s returns compounded over
the period, which will very likely differ from 200% of the return
of the Underlying Security’s shares over the same period. The Fund
will lose money if the Underlying Security’s performance is flat
over time, and because of daily rebalancing, the Underlying
Security’s shares’ volatility and the effects of compounding, the
Fund may lose money over time while the Underlying Security’s
performance increases over a period longerthan a single day. As a
consequence, investors should not plan to hold shares of the Fund
unmonitored for periods longer than a single trading day.
Defiance ETFs LLC is the ETF sponsor. The Fund’s investment
adviser is Tidal Investments, LLC (“Tidal” or the “Adviser”).
Investing involves risk. Principal loss is
possible.
There is no guarantee that the Fund’s investment strategy will
be properly implemented, and an investor may lose some or all of
its investment.Underlying Security Risk. The
underlying security is subject to many risks that can negatively
impact the Fund.
Fixed Income Securities Risk. When the Fund
invests in fixed income securities, the value of your investment in
the Fund will fluctuate with changes in interest rates. Typically,
a rise in interest rates causes a decline in the value of fixed
income securities owned by the Fund.
Leverage Risk. Leverage may increase the risk
of loss and cause fluctuations in the market value of the Fund's
portfolio to have disproportionately large effects or cause the NAV
of the Fund generally to decline faster than it would
otherwise.
Derivatives Risk. Derivatives may be more
sensitive to changes in market conditions and may amplify
risks.
Foreign and Emerging Markets Risks. Investments
in foreign securities may involve risks such as social and
political instability, market illiquidity, exchange-rate
fluctuations, a high level of volatility and limited regulation.
Investing in emerging markets involves different and greater risks,
as these countries are substantially smaller, less liquid and more
volatile than securities markets in more developed markets.
Effects of Compounding and Market Volatility
Risk. The Fund has a daily leveraged investment objective
and the Fund's performance for periods greater than a trading day
will be the result of each day's returns compounded over the
period, which is very likely to differ from the Fund performance,
before fees and expenses.
Single Issuer Risk. Issuer-specific attributes
may cause an investment in the Fund to be more volatile than a
traditional pooled investment which diversifies risk or the market
generally. The value of the Fund, which focuses on an individual
security, may be more volatile than a traditional pooled investment
or the market as a whole and may perform differently from the value
of a traditional pooled investment or the market as a whole.
Swap Agreements. The use of swap transactions
is a highly specialized activity, which involves investment
techniques and risks different from those associated with ordinary
portfolio securities transactions. These risks may prevent the Fund
from achieving its leveraged investment objective, even if the
Underlying Security later reverses all or a portion of its
movement.
Counterparty Risk. The Fund is subject to
counterparty risk by virtue of its investments in derivatives which
exposes the Fund to the risk that the counterparty will not fulfill
its obligation to the Fund.
Non-Diversification Risk. Because the Fund is
“non-diversified,” it may invest a greater percentage of its assets
in the securities of a single issuer or a smaller number of issuers
than if it was a diversified fund. As a result, a decline in the
value of an investment in a single issuer or a smaller number of
issuers could cause the Fund’s overall value to decline to a
greater degree than if the Fund held a more diversified
portfolio.
New Fund Risk. As of the date of this
prospectus, the Fund has no operating history and currently has
fewer assets than larger funds. Like other new funds, large inflows
and outflows may impact the Fund's market exposure for limited
periods of time.
Brokerage Commissions may be charged on trades.
LLYX is distributed by Foreside Fund Services, LLC.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/9351ca06-27a3-4aff-bb7d-66672f8db977
David Hanono
Defiance ETFs
+1 833-333-9383